TY  - GEN
AU  - Babb,J S
AU  - Rogatko,A
TI  - Patient specific dosing in a cancer phase I clinical trial
SN  - 0277-6715
PY  - 2001///0823
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Antibodies
KW  - blood
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Clinical Trials, Phase I as Topic
KW  - methods
KW  - Dose-Response Relationship, Drug
KW  - Gastrointestinal Neoplasms
KW  - Humans
KW  - Research Design
KW  - Statistics as Topic
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1002/sim.848
ER  -